345
Views
5
CrossRef citations to date
0
Altmetric
Review

Developing immunotherapeutic strategies to target brain tumors

, &
Pages 775-788 | Received 05 Apr 2016, Accepted 18 May 2016, Published online: 13 Jun 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Erin Crotty, Kira Downey, Lauren Ferrerosa, Catherine Flores, Bindu Hegde, Scott Raskin, Eugene Hwang, Nicholas Vitanza & Hideho Okada. (2021) Considerations when treating high-grade pediatric glioma patients with immunotherapy. Expert Review of Neurotherapeutics 21:2, pages 205-219.
Read now
Nicole A. P. Lieberman, Nicholas A. Vitanza & Courtney A. Crane. (2018) Immunotherapy for brain tumors: understanding early successes and limitations. Expert Review of Neurotherapeutics 18:3, pages 251-259.
Read now

Articles from other publishers (3)

Ying Wang, Peng Li, Bo Wang, Shuai Wang & Pinan Liu. (2019) Identification of myeloid-derived suppressor cells that have an immunosuppressive function in NF2 patients. Journal of Cancer Research and Clinical Oncology 145:2, pages 523-533.
Crossref
Wojciech K. Panek, J. Robert Kane, Jacob S. Young, Aida Rashidi, Julius W. Kim, Deepak Kanojia & Maciej S. Lesniak. (2017) Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma. Oncotarget 8:51, pages 89391-89405.
Crossref
Thangirala Sudha, Dhruba J. Bharali, Stewart Sell, Noureldien H. E. Darwish, Paul J. Davis & Shaker A. Mousa. (2017) Nanoparticulate Tetrac Inhibits Growth and Vascularity of Glioblastoma Xenografts. Hormones and Cancer 8:3, pages 157-165.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.